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importance of this study is that tigecycline may be a
therapeutic option for chronic osteomyelitis resistant Acine-
tobacter sp, under which treatment options are very limited.
doi:10.1016/j.ijid.2010.02.1932200 14
f infections. The widespread use of quinolones for this and
ther reasons has led to an increase in resistant bacteria.
ims of this study: to evaluate the efﬁcacy of single-dose
entamicin in comparison with single dose of oﬂoxacin in
atients underwent transrectal ultrasound guided biopsy of
rostate.
Methods: 109 patients undergoing a prostate biopsy were
andomly assigned to two groups: the ﬁrst group was treated
ith a single dose of oﬂoxacin (400mg) prior to the biopsy
nd the second with a single dose of gentamicin (3mg/kg).
linical signs and symptoms, and urine tests and cultures
ere followed 2 and 7 days after procedure.
Results: 57 patients received Oﬂoxacin and 52 Gentam-
cin. 3 patients in the Oﬂoxacin group (5.2%) and 4 in the
entamicin group (7.6%) developed urinary tract infections
N.S). No diferences were seen in the clinical outcome
etween the groups.
Conclusion: The development of quinolone resistant
acteria has led us to examine alternative options for pro-
hylactic treatment before prostate biopsies. Gentamicin,
as as efﬁcient as quinolones in the prevention of urinary
ract infections. A single dose prior to the procedure is suf-
cient and longer treatment duration is unnecessary.
oi:10.1016/j.ijid.2010.02.1930
0.005
educing inappropriate antibiotic usage and costs in
n academic Hematology-Oncology unit via antimicrobial
tewardship
.L. Yeo ∗, T.S. Wu, R. Lim, P.A. Tambyah, L.Y. Hsu
National University Health System, Singapore, Singapore
Background: Rising consumption of broad spectrum
ntimicrobials and increasing prevalence of resistant
athogens have raised concerns about antimicrobial use
n recent years. Antimicrobial stewardship programs have
een reported to improve patient and institutional outcomes
hile potentially reducing cost and resistance rates. In the
ight of these ﬁndings, an antimicrobial stewardship program
ASP) was initiated in a tertiary care hospital in Singapore.
Methods: The program was initiated in July 2009
nd piloted in the haematology-oncology department. A
rospective audit and feedback mechanism was employed
or review of patients on selected broad spectrum antimi-
robials. Appropriateness for use was assessed based on
ndication of therapy, dose of antimicrobials used, and dura-
ion of therapy. Recommendations were made by infectious
isease physicians to the primary team in writing. Appropri-
teness of use, recommendations made, patient savings and
linical outcomes were analyzed for a period of four months
fter initiation of the program.
Results: A total of 462 cases were reviewed of which 64%
f them were appropriate. The most commonly prescribed
ntimicrobials were piperacillin/tazobactam, ceftazidime
nd imipenem, making up 19%, 16% and 15% of the cases
udited respectively. Among the recommendations made,
e-escalation and discontinuation of antimicrobials were the
ost common, eachmaking up 27% of the recommendations.
his was followed by recommendations for IV-to-PO switch
nd advice on treatment duration, which made up 11% ofternational Congress on Infectious Diseases (ICID) Abstracts
he recommendations each. The overall acceptance rate of
he recommendations was 89%. An estimate of the potential
atient savings due to the accepted recommendations came
p to $24, 590 over the four months period. There was no
igniﬁcant negative impact on clinical outcomes following
he recommendations.
Conclusion: ASP has demonstrated its impact in reduc-
ng unnecessary use of broad spectrum antimicrobials and
ost to patients. Extension of the program is likely to reduce
election pressure for drug-resistant pathogens in the insti-
ution and decrease antimicrobial expenditure.
oi:10.1016/j.ijid.2010.02.1931
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igecycline usage in osteomielitis caused by multidrug-
esistent acinetobacter: A report of 10 cases from a single
nstitution
.M. Ruiz1, E. Gayoso2,∗, Y. Vasquez3
Hospital militar, Caracas, DC, Venezuela
Hospital Millitar, caracas, DC, Venezuela
Hospital Militar Dr. carlos Arvelo, Caracas, DC, Venezuela
Background: Acinetobacter infectious has been identiﬁed
n soldiers who participated in wars as Korean, Vietnam and
iddle Orient, by now the therapeutics options are limited
or this type of multidrug resistant microorganism, we know
hat the use is not approved for de treatment a bone infec-
ious, so we found necessary to evaluate the efﬁcacy of
igecycline in the treatment of this entity.
Methods: We identiﬁed 10 patients with chronic
steomielitis during 2007-2008, this study of cases is
rospective, descriptive analytical, we use the microbio-
ogical method of Kirby-Bauer and the criteria of inclusion
ere patients with clinical diagnosis, microbiology isolation,
maging and bone biopsy. Exclusion criteria: inmunocompro-
ised and pregnant woman.
Results: 10 patients completed the study; the 88% were
ales, age 19 to 72 years, mean 39 years. The more com-
on location were: hip, femur, tibia, sacrum and calcaneus.
he risk factors identiﬁcated were: open fracture, vascular
ompromise, prolong use of antibiotic, long stay and re-
nterventions. Positive cultures for A. baumannii 100%. They
eceived different regimens of antibiotics without success,
t this time we began with tigecycline IV 100mg the ﬁrst
ay and then 50mg IV q 12hs for 6-7 weeks, all the patients
ncluded a combined surgical and medical management.
Conclusion: 90% showed clinical improvement, and the
